PNC Financial Services Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205M Sell
3,379,304
-54,230
-2% -$3.16M 0.12% 129
2025
Q4
$185M Sell
3,433,534
-225,894
-6% -$10.9M 0.1% 138
2025
Q3
$165M Sell
3,659,428
-480,848
-12% -$22.5M 0.1% 149
2025
Q2
$192M Sell
4,140,276
-244,442
-6% -$12M 0.12% 124
2025
Q1
$267M Sell
4,384,718
-55,242
-1% -$3.22M 0.14% 94
2024
Q4
$251M Sell
4,439,960
-29,705
-0.7% -$1.66M 0.17% 97
2024
Q3
$231M Sell
4,469,665
-129,324
-3% -$6.07M 0.15% 105
2024
Q2
$191M Sell
4,598,989
-149,887
-3% -$6.71M 0.13% 117
2024
Q1
$258M Sell
4,748,876
-31,449
-0.7% -$1.6M 0.18% 91
2023
Q4
$245M Sell
4,780,325
-191,569
-4% -$10.1M 0.19% 90
2023
Q3
$289M Sell
4,971,894
-111,818
-2% -$6.85M 0.25% 75
2023
Q2
$325M Sell
5,083,712
-57,333
-1% -$3.84M 0.28% 69
2023
Q1
$356M Sell
5,141,045
-33,467
-0.6% -$2.36M 0.31% 60
2022
Q4
$372M Sell
5,174,512
-29,126
-0.6% -$2.2M 0.36% 55
2022
Q3
$370M Sell
5,203,638
-188,056
-3% -$13.6M 0.39% 51
2022
Q2
$415M Sell
5,391,694
-69,503
-1% -$5.29M 0.41% 52
2022
Q1
$399M Sell
5,461,197
-29,023
-0.5% -$1.95M 0.35% 60
2021
Q4
$342M Sell
5,490,220
-142,307
-3% -$8.35M 0.28% 80
2021
Q3
$333M Sell
5,632,527
-1,179,643
-17% -$77.7M 0.31% 72
2021
Q2
$455M Sell
6,812,170
-135,275
-2% -$8.82M 0.41% 55
2021
Q1
$439M Sell
6,947,445
-118,148
-2% -$7.35M 0.43% 54
2020
Q4
$438M Sell
7,065,593
-101,218
-1% -$6.22M 0.44% 52
2020
Q3
$432M Buy
7,166,811
+103,674
+1% +$6.24M 0.53% 43
2020
Q2
$415M Buy
7,063,137
+781,271
+12% +$46.7M 0.55% 41
2020
Q1
$350M Buy
6,281,866
+69,345
+1% +$4.24M 0.44% 46
2019
Q4
$399M Buy
6,212,521
+56,097
+0.9% +$3.21M 0.39% 56
2019
Q3
$312M Sell
6,156,424
-127,968
-2% -$6.01M 0.31% 65
2019
Q2
$285M Sell
6,284,392
-597,928
-9% -$27.9M 0.28% 75
2019
Q1
$328M Buy
6,882,320
+33,927
+0.5% +$1.69M 0.33% 65
2018
Q4
$356M Buy
6,848,393
+356,482
+5% +$19.2M 0.4% 55
2018
Q3
$403M Buy
6,491,911
+872,789
+16% +$51.8M 0.38% 53
2018
Q2
$311M Sell
5,619,122
-150,990
-3% -$8.15M 0.31% 69
2018
Q1
$365M Sell
5,770,112
-197,169
-3% -$12.7M 0.36% 56
2017
Q4
$366M Sell
5,967,281
-106,070
-2% -$6.63M 0.35% 58
2017
Q3
$387M Sell
6,073,351
-64,279
-1% -$3.75M 0.4% 51
2017
Q2
$342M Sell
6,137,630
-158,905
-3% -$8.65M 0.37% 62
2017
Q1
$342M Sell
6,296,535
-175,566
-3% -$9.63M 0.38% 54
2016
Q4
$378M Sell
6,472,101
-131,283
-2% -$7.18M 0.43% 41
2016
Q3
$356M Sell
6,603,384
-196,072
-3% -$12.6M 0.41% 43
2016
Q2
$500M Sell
6,799,456
-111,040
-2% -$7.85M 0.59% 26
2016
Q1
$441M Sell
6,910,496
-144,601
-2% -$9.12M 0.52% 34
2015
Q4
$485M Sell
7,055,097
-217,384
-3% -$14.4M 0.57% 27
2015
Q3
$431M Sell
7,272,481
-209,358
-3% -$13.3M 0.51% 32
2015
Q2
$498M Sell
7,481,839
-191,902
-3% -$12.6M 0.56% 26
2015
Q1
$495M Sell
7,673,741
-364,271
-5% -$22.8M 0.54% 27
2014
Q4
$474M Sell
8,038,012
-213,638
-3% -$12M 0.52% 31
2014
Q3
$422M Buy
8,251,650
+1,009,341
+14% +$50.4M 0.5% 39
2014
Q2
$351M Sell
7,242,309
-130,796
-2% -$6.45M 0.45% 43
2014
Q1
$383M Sell
7,373,105
-158,288
-2% -$8.42M 0.5% 35
2013
Q4
$400M Sell
7,531,393
-257,940
-3% -$13.1M 0.53% 31
2013
Q3
$360M Sell
7,789,333
-429,315
-5% -$18.8M 0.53% 34
2013
Q2
$367M Buy
+8,218,648
New +$357M 0.54% 35

Other funds holding BMY

PNC Financial Services Group's BMY Position: Q1 2026 in Review

PNC Financial Services Group reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, selling an estimated $3.16M and leaving 3,379,304 shares worth $205M. The position accounts for 0.12% of the portfolio, ranked #129.

PNC Financial Services Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $500M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • PNC Financial Services Group held 3,379,304 shares of Bristol-Myers Squibb worth $205M as of Q1 2026.
  • PNC Financial Services Group sold 54,230 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.16M.
  • Bristol-Myers Squibb made up 0.12% of PNC Financial Services Group's portfolio in Q1 2026, its #129 holding.
  • PNC Financial Services Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Bristol-Myers Squibb position peaked at $500M in Q2 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.